Drug bezoars

Prescrire International

Volumn 8, Issue 39, 1999, Pages 20-21

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; LAXATIVE;

BEZOAR; DRUG RELEASE; INTESTINE OBSTRUCTION; SHORT SURVEY;

BEZOARS; HUMANS; PHARMACEUTICAL PREPARATIONS; RISK FACTORS;

EID: 0032894492     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (38)

1. th ed. Maloine, Paris 1995: 112.
2. Robles R et al. 'Gastrointestinal bezoars' Br J Surg 1994; 81: 1000-1001.
3. Thompson KC and Iredale JP "Bezoars. Implicated drugs and avoidance strategics" Drug Saf 1996; 14 (2): 85-93.
4. Iredale JP and George CF "Drugs causing gastrointestinal obstruction" Adverse Drug React Toxicol Rev 1993; 12(3): 163-175.
5. Stack PE and Thomas E "Pharmacobezoar an evolving new entity" Dig Dis 1995; 13: 356-364.
6. Townsend CM et al. "Intestinal obstruction from medication bezoar in patients with renal failure" N Engl JMedl973;288: 1058-1059.
7. Hurley JK "Bowel obstruction occuring in a child during treatment with aluminium hydroxide gel" J Pediatr 1978; 92 (4): 592-593.
8. Korenman MD et al. "Intestinal obstruction from medication bezoars" JAMA 1978; 240 (1): 54-55.
9. Algozzine GJ et al. "Sucralfate bezoar" N Engl J Med 1983; 309 (22): 1387.
10. Strozik KS et al. "Bezoar in a preterm baby associated with sucral-fate" Clin Pediatr 1996; 35 (8): 423-424.
11. Razafimahefa H et al. "Bézoard œsophagien chez un enfant traité par sucralfate" Arch Pediatr 1997; 4 (7): 659-661.
12. Sandeman DR et al. "esophageal obstruction due to hygroscopicgum laxative" Lancet 1980; i: 364-365.
13. Frohna WJ "Metamucil bezoar:an unusual cause of small bowelobstruction" Am J Emerg Med 1992;10 (4): 393-395.
14. "Carmellose". In: "Martindale The Extra Pharmacopeia" 31" ed. The Pharmaceutical Press, London 1996: 1536-1537.
15. o" Re v Pré scr 1997; 17 (171): 224.
16. Food and Drug Administration "McdWatch - case studies - Guar Gum (Calban): OTC product recalled and reclassified": text consulted on 17/10/1997 on the PDA Internet site (http://www. fda.govsearch97cgi): 1 page.
17. Ohlsson A and Hosking M. "Complications following oral administration of exchange resins in extremely low-birth-weight infants" Eur J Pediatr 1987; 146: 571-574.
18. Foresti V "Intestinal obstruction due to kayexalate in a patient concurrently treated with aluminium hydroxide and morphine sulfate" Clin Nephrol 1994; 41 (4): 252.
19. Hunt-Fugate AK and Schmidt HJ "Cecal vitamin bezoar formation inducing abdominal discomfort" Ann Pharmacother 1992; 26: 485-487.
20. Cremer SA and Gelfand DW "Esophageal bezoar resulting from enterai feeding" JParenter Enter Nutr 1996; 20 (5): 371-373
21. Faverge B and Gratecos LA "Lactobézoard gastrique du nourrisson induit par Gélopectose"" Pédiatrie 1997; 42: 685-686.
22. Springer DJ and Groll A 'Poisoning with enteric-coated acetylsalicylic acid complicating gastric outlet obstruction" Can MedAssoc J1980; 122: 1032-1034.
23. Bogacz K and Caldron P "Enteric-coated aspirin bezoar elevation of serum salicylate level by barium study" Am J Med 1987; 83: 783-786.
24. Buckley NA et al. "Controlled release drugs in overdose. Clinical considerations" Drug Sa/1995; 12 (1): 73-84.
25. "Controlled release formulations delay and prolong clinical effects following overdose" Drugs Tlier Perspect 1995; 5 (7): 11-13.
26. Stack PE et al. "Pharmacobezoars- The Irony of the antidote: first case report of nifedipine XL bezoar" JClin Gastroenterol\994; 19 (3): 264265.
27. Sheperd MF "Bezoar formed by fragments of extended-release nifedipine tablets" Clin Pharm 1993; 12: 849-852.
28. Georgopoulos S and Gerdcs H "Retention of nifedipine extended release tabs in a patient-'with a colonie stricture" Am J Gaslroenterol 1995; 90 (12): 2224-2226.
29. Kvvon HY et al. "Small bowel procardia XL tablet bezoar mimicking cystic pneumatosis intestinalis" Abdom Imaging 1996; 21: 142-144.
30. Bernstein G et al. "Failure of gastric emptying and charcoal administration in fatal sustained-release theophylline overdose: pharmacobezoar formation" Ann Emerg Med 1992; 21 (11): 1388-1390.
31. Smith WDF "Endoscopie removal of a pharmacobezoar of slow release theophylline" BMJ 1987; 294: 125.
32. Cereda JM et al. "Endoscopie removal of pharmacobezoar of slow release theophylline" BMJ I986; 293: 1143.
33. Coupe M "Self-poisoning with sustained-release aminophylline: a mechanism for observed secondary rise in serum theophylline" Human Toxicol 1986; 5: 341-342.
34. Sporer KA and Manning JJ "Massive ingestion of sustainedrelease verapamil with a concretion and bowel infarction" Ann Emerg Med\991;22 (3): 603-605.
35. Thornley-Brown D et al. "Lithium toxicity associated with a ' trichobezoar" Ann Intern Med 1992; 116 (9): 739-740.
36. o found in the stools" Prescr Intern 1992; 1 (1): 19.
37. Florence AT and Jani PU "Novel oral drug formulations: their potential in modulating adverse effects" Drug Safety 1994; 10 (3): 233-266.
38. Rey A et al. "Dictionnaire historique de la langue française" Dictionnaires le Robert éd., Paris 1992:213